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Abstract
Background: Signal regulate protein a (SIRPa) is involved in many functional aspects of monocytes. Here we investigate the
role of SIRPa in regulating b2 integrin-mediated monocyte adhesion, transendothelial migration (TEM) and phagocytosis.
Methodology/Principal Findings: THP-1 monocytes/macropahges treated with advanced glycation end products (AGEs)
resulted in a decrease of SIRPa expression but an increase of b2 integrin cell surface expression and b2 integrin-mediated
adhesion to tumor necrosis factor-a (TNFa)–stimulated human microvascular endothelial cell (HMEC-1) monolayers. In
contrast, SIRPa overexpression in THP-1 cells showed a significant less monocyte chemotactic protein-1 (MCP-1)–triggered
cell surface expression of b2 integrins, in particular CD11b/CD18. SIRPa overexpression reduced b2 integrin-mediated firm
adhesion of THP-1 cells to either TNFa–stimulated HMEC-1 monolayers or to immobilized intercellular adhesion molecule-1
(ICAM-1). SIRPa overexpression also reduced MCP-1–initiated migration of THP-1 cells across TNFa–stimulated HMEC-1
monolayers. Furthermore, b2 integrin-mediated THP-1 cell spreading and actin polymerization in response to MCP-1, and
phagocytosis of bacteria were both inhibited by SIRPa overexpression.
Conclusions/Significance: SIRPa negatively regulates b2 integrin-mediated monocyte adhesion, transendothelial migration
and phagocytosis, thus may serve as a critical molecule in preventing excessive activation and accumulation of monocytes
in the arterial wall during early stage of atherosclerosis.
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Introduction
Recruitment of monocytes from circulation to inflamed tissues
plays a pivotal role in the initiation and progression of
atherosclerosis [1,2,3]. After migrated to lesion region, monocytes
are rapidly differentiated into macrophage which engulf lipids and
form the fatty streak [4]. Although the mechanisms that govern the
delivery of monocytes from circulation to inflammatory site are
not fully understood, the process of monocyte diapedesis has been
regarded as a multi-step event that is sequentially regulated by a
panel of adhesion molecules and signaling pathways. E- and P-
selectins are involved in the initial reversible adherence of
monocytes to the endothelial cell monolayers [5]. The following
firm adhesion is mediated by monocyte b2 integrins,including
CD11a/CD18 and CD11b/CD18,that recognize vascular cell
adhesion molecule-1(VCAM-1) and intercellular adhesion mole-
cule-1 (ICAM-1) on endothelial cells [6]. Firm adhesion of
monocytes requires activation of integrins, which can be triggered
by agonist-induced activation of G protein–coupled chemokine
receptors [7]. Monocytes express CC chemokine receptor 2
(CCR2), which binds monocyte chemoattractant protein-1 (MCP-
1), leading to b2 integrin-mediated firm adhesion and subsequent
transmigration of adhered monocytes through the vascular
endothelium [8].
Recently signal regulatory protein a (SIRPa) (also designate as
SHPS-1[9], p84[10], BIT[11], MFR[12], MyD-1[13], etc.) has
been reported to serve as an important modulator for controlling
leukocyte inflammatory responses [14,15]. As an immunoglobulin
superfamily member (IgSF), SIRPa is expressed mainly by
myeloid. SIRPa has a long intracellular domain that contains
four tyrosine residues to form two immunoreceptor tyrosine-based
inhibition motifs (ITIMs) and this type of signaling structure is
highly conserved between mice, rats and humans. Studies have
suggested that binding of SIRPa with its extracellular ligand CD47
results in phosphorylations of SIRPa ITIMs, which in turn, leads
to their association with SH2-domain-containing protein tyrosine
phosphotases SHP-1 and SHP-2 [16,17] to delivers signals that
regulate a variety of cellular functions [14]. Ligation of SIRPa by
antibody or CD47 recombinant inhibits many leukocyte functions,
including phagocytosis[18,19], tumour-necrosis factor produc-
tion[20] and in vitro transmigration[21,22]. Activation of SIRPa
by arterial elastic laminae also inhibits monocyte adhesion[23].
Fibroblasts expressing a SIRPa mutant lacking ITIMs-containing
cytoplasmic tail showed increased formation of focal adhesions
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matrix, suggesting that SIRPa also plays a role in integrin-
mediated cytoskeletal organization [24]. Negative regulatory role
of SIRPa has also been found in tumor metastasis, survival, and
cell transformation [25].
Inthepresentstudy,tofurtherexplorethenegativeregulatoryrole
of SIRPa in various functional aspects of monocytes, we examined
the correlation between expression level of SIRPa in THP-1 cells
and THP-1 cell transmigratory capacity. By overexpressing SIRPa
in THP-1 cells, we also determined the alteration of b2 integrin
expression and b2 integrins-mediated cellularfunctions ofmonocytes
in response to chemoattractant stimulation.
Materials and Methods
Reagents and Antibodies
Recombinant human MCP-1 and TNFa, were purchased from
PeproTech (Rocky Hill, NJ). AGEs-BSA (AGEs) was prepared
according to a method previously described [26]. Briefly, 50 mg/
ml bovine serum albimin (BSA) (Fraction V, sterile filtered, Sigma-
Aldrich) was incubated with 0.6 M D-ribose or 0.5 M D-glucose
and 0.3 M lysine in PBS containing 100 units/ml penicillin and
streptomycin for 4 weeks. The unincorporated sugars were
removed by dialysis against PBS. Polyclonal anti-human CD11b
were generated against C-terminal peptide of CD11b [27].
Polyclonal anti-SIRPa antibody (SIRPa-ct) was obtained from
Chemicon (Temecula, CA). Monoclonal anti-CD11b (OKM-1),
and anti-CD11a (TIB-217), prepared in our laboratory from
hybridoma, were obtained from American Type Culture Collec-
tion (ATCC) (Manassas, VA). Monoclonal anti-CD11c (S-HCL-3,
IgG2b) and anti-CCR2 (clone 48607) were obtained from BD
Biosciences (San Diego, CA).
Cells
THP-1 cells (Chinese Cell Culture Center, Shanghai, China)
were cultured and maintained as described [8]. In separated
experiments, THP-1 cells were treated with AGEs-BSA (AGEs) at
various concentrations overnight. Cells treated with BSA of the
same concentration served as controls. Immortalized HMEC-1
was kindly provided by Dr. E.W. Ades (Centers for Disease
Control and Prevention, Atlanta, GA)[28] and were grown in
MCDB-131 (Invitrogen) supplemented with 10 ng/ml epidermal
growth factor (Becton-Dickinson), 1 mg/ml hydrocortisone (Sig-
ma-Aldrich) and 10–15% fetal bovine serum (Hyclone). HMEC-1
cells were seeded on collagen (Sigma-Aldrich)-coated tissue culture
plates or permeable Transwell filters (5.0 mm pore size, 0.33 cm
2
surface areas, Costar, NY).
SIRPa Overexpression
Complete sequence of human SIRPa was amplified, inserted into
the expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA), and
confirmed by DNA sequencing. The transfection of THP-1 cells was
conducted via Lipofectmin 2000 (Invitrogen). Briefly, Lipofectmin-
SIRPa pcDNA3.1 complex (250 mL) was added dropwise to 5610
6
THP-1 cells in 20 mL RPMI medium 1640 containing 2% heat-
inactivated fetal bovine serum. After 24 h incubation, THP-1 cells
were harvested and used for further analysis.
Immunofluorescence, Confocal Microscopy and Flow
Cytometry
Surface expressions of b2-integrins were detected using flow
cytometry as described [8,29]. The relative surface expression was
estimated by subtracting the mean fluorescence intensity (MFI) of
cells labeled with the nonspecific antibody from that of cells
labeled with the antibodies detecting b2-integrins. All studies
consisted of at least three independent experiments. Flow
cytometry was performed and data were analyzed using
CELLQUEST software (BD Biosciences). The polymerization of
actin filaments in THP-1 cells, induced by pretreatment with
10 nM MCP-1 or 25 ng/mL TNFa for 30–60 minutes, was
determined using rhodamine-conjugated phalloidin staining
(Molecular Probes) according to the manufacturer’s protocol.
Briefly, cells treated with cytokines were fixed with 3.7%
paraformaldehyde in PBS for 5 minutes, gently permeabilized
with 0.1% Triton X-100, and blocked with 1% BSA in PBS for
30 min followed by rhodamine-conjugated phalloidin staining. In
some experiments, cells were treated with cytochalasin D (Sigma-
Aldrich) to inhibit actin polymerization [30]. Coverslips were
mounted with antifade mounting medium (Molecular Probes).
Images were captured and analyzed by a laser scanning confocal
microscope equipped with an image processing system (Olympus
Microsystems).
Cell Adhesion Assays
Confluent HMEC-1 cell monolayers cultured on gelatin
(Difco)–coated tissue culture plates or permeable Transwell filters.
Monolayers were treated with 25 ng/mL TNFa for 6 h to induce
VCAM-1 and ICAM-1 expression prior to the adhesion assay
[31,32]. In separate experiments, 24-well plates were coated for
2 h with 10 mg/mL human recombinant VCAM-1 or ICAM-1.
THP-1 cells were briefly labeled with 29,79-bis-(2-carboxyethyl)-6-
carboxyfluorescein acetoxymethyl ester (BCECF-AM, Molecular
Probes)[27] and then suspended in RPMI 1640 medium
containing 0.1% BSA and stimulated with 10 nM MCP-1 for
30 min to activate integrins [30]. In a subset of experiments,
monocytes were pre-incubated with 50 mM dibutyl-cAMP
(Bt2cAMP) for 30 min to inhibit chemokine-mediated integrin
activation. Fluorescently labeled monocytes (,2610
5 cells/well)
were then added to HMEC-1 monolayers or 24-well plates coated
with VCAM-1 or ICAM-1, and incubated for 30 min at 37uC.
Nonadherent monocytes were removed by gentle washing with
PBS and the bound cells were measured by a fluorescence plate
reader at excitation/emission wavelengths of 485/535 nm (Milli-
pore, Milford, MA)[27].
Transendothelial Migration (TEM)
Migration of THP-1 cells across TNFa–pre-activated HMEC-1
monolayers was performed as previously described [30] with
minor modification. Prior to migration assay, HMEC-1 monolay-
ers cultured on gelatin (Difco)–coated transwell filters were treated
with 25 ng/mL TNFa for 6 h. THP-1 cells (5.0610
5/per well)
were added to the upper chamber of Transwell inserts containing
200 ml HBSS. 700 ml HBSS containing 10 nM MCP-1 was placed
in the bottom chamber. After 90 min and 180 min incubation at
37uC under 5% CO2, cells that had transmigrated to the lower
chamber were harvested in 1 ml PBS containing 0.1% BSA and
labeled with phycoerythrin (PE)-conjugated anti-human CD14
antibody. 10
6 FITC-conjugated standard beads (PharMingen, La
Jolla, CA) were added to the cell suspension and the number of
THP-1 cells was counted until 10,000 beads were counted by flow
cytometry. All experiments were repeated as triplicated fashion in
at least three independent studies.
Phagocytosis of Fluorescein Conjugated Bacteria
THP-1 cells transfected with SIRPa or Mock vector were
incubated for 3 h with 100 ml of fluorescein-conjugated E. coli K-
12 bioparticles (Molecular Probes) [33]. The E. coli suspension was
aspirated, and after three washes with Hank’s balanced salt
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2+ and Mg
2+ (HBSS
2), cell associated
fluorescence was observed under microscopy or measured using a
SpectraMax microtiter plate reader (Molecular Devices).
Western Blot
THP-1 cells were solubilized in lysis buffer containing 1%
Triton X-100 and a panel of protease inhibitors at 4uC. Pellet was
removed after centrifuged at 13,0006g for 5 minutes. Supernatant
was normalized for total protein, and loaded on 10% SDS-PAGE.
After electrophoresis and transfer onto Hybond membranes,
membranes were blocked with 5% non-fat milk. Antigens
were detected using suitable primary antibodies followed by
incubation with HRP-conjugated antibodies and ECL (Amer-
sham) detection.
Statistical Analysis
Data were analyzed by the Student t test; P values of ,0.05
were regarded as significant differences (*, p,0.05; **, p,0.01).
Results
Downregulation of SIRPa in THP-1 cells is correlated with
enhanced b2 integrin-mediated cell adhesion
It has been reported that advanced glycation end products
(AGEs) are involved in tissue damage associated with diabetic
complications and aging [34,35]. Although the mechanism is still
not clear, monocytes tend to be activated by AGEs and show an
enhanced chemotaxis under such inflammatory conditions. As
shown by Western blot analysis in Figure 1A, the expression of
SIRPa in THP-1 cells was decreased after AGEs treatment.
Served as controls, b-actin level was not altered. The down-
regulation of SIRPa in AGEs–treated THP-1 cells is contrast to
that of receptor for advanced glycation end products (RAGE) and
junctional adhesion molecule-like protein (JAML), which expres-
sion levels are both increased after AGEs treatment (Zen et al,
unpublished). Fig. 1B showed the quantitative analysis of SIRPa
downregulation by AGEs in a dose-dependent fashion. Interest-
Figure 1. Down-regulation of SIRPa in THP-1 cells treated with BSA-AGEs is correlated to enhanced THP-1 cell surface expression of
leukocyte b2 integrins and b2 integrins-mediated THP-1 cell inflammatory responses. In these experiments, THP-1 cells were treated with
BSA-AGEs (AGEs) or BSA overnight at 37uC. A: SIRPa protein level in THP-1 cells; B: reduction of SIRPa protein level by AGEs in dose-dependent
fashion; C: Cell surface expression level of b2 integrins in THP-1 cells; D and E: THP-1 cell adhesion to and migration across TNFa–pre-activated HMEC-
1 monolayers, respectively. All data are mean6SD (n=3) of three independent experiments.
doi:10.1371/journal.pone.0003291.g001
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cell surface expression of b2 integrins, in particular CD11b/CD18,
in response to the stimulation of MCP-1 (Fig. 1C). Also, compared
to BSA–treated THP-1 cells, AGEs– treated THP-1 cells had a
higher percentage of cell adhesion to TNFa–activated HMEC-1
monolayer (Fig. 1D). In response to MCP-1, AGEs–treated THP-
1 cells also showed an increased transmigration across TNFa–
activated HMEC-1 monolayers compared to THP-1 cells treated
with BSA (Fig. 1E). Together, these results suggest that AGEs
treatment can activate THP-1 cells and enhance cell chemotaxis.
Overexpression of SIRPa in THP-1 cells inhibits MCP-1–
induced cell surface expression of b2 integrins
To define the role of SIRPa in regulating monocyte
inflammatory response, we characterized the alteration of b2
integrin expression and b2 integrin-mediated cell adhesion,
migration and phagocytosis in THP-1 cells after significantly
increase SIRPa expression level. As shown in Figure 2A,
immunoblot analysis showed that the delivery of the pcDNA3.1
vector encoding human SIRPa into THP-1 cells profoundly
enhanced SIRPa expression. Compared to mock–transfected
THP-1 cells, SIRPa–transfected THP-1 cells also showed a
significantly enhanced expression of SIRPa on cell surface, as
indicated by flow cytometry (Fig. 2B).
Similar to circulating monocytes,THP-1 cells normally express b2
integrins [8,36,37] and their cell surface expression levels are rapidly
up-regulated by chemoattractants during inflammatory response.
We next determined the alteration of cell surface expression of
CD11b/CD18 and CD11a/CD18 in SIRPa– or mock–transfected
THP-1 cells. In these experiments, SIRPa– or mock–transfected
THP-1 cells were treated with or without 10 nM MCP-1 for 30 min
and then directly labeled with PE-conjugated mouse IgG specific for
human CD11a, CD11b, and CC chemokine receptor 2 (CCR2),
and surface expression was analyzed using flow cytometry. The
results showed that SIRPa overexpression in THP-1 cells did not
affect the basal level of b2 integrin expression on cell surface but
significantly reduced the up-regulation of cell surface b2 integrin
expression by MCP-1 (Fig. 2C).
SIRPa overexpression affects CD11b/CD18-mediated
THP-1 cell functions in response to MCP-1 stimulation
Chemokines such as MCP-1 has been reported to trigger
integrin–mediated firm adhesion and subsequent transmigration of
monocytes [8]. As shown in Figure 3A, MCP-1–stimulated THP-1
cells showed a significant integrin-mediated firm adhesion to
TNFa–activated HMEC-1 monolayers. However, this firm
adhesion was largely reduced in THP-1 cells with SIRPa
overexpression. Since TNFa–stimulated HMEC-1 monolayers
express both VCAM-1 and ICAM-1, the specific ligands for b1
and b2 integrins, respectively, additional adhesion assays were
performed using plates coated with human recombinant ICAM-1
or VCAM-1, respectively. To estimate background adhesion,
control adhesion assays were performed using THP-1 cells
pretreated with Bt2cAMP, a permeable analogue of cAMP that
blocks integrin-dependent firm adhesion triggered by MCP-1 [30].
SIRPa–transfected THP-1 cells did not show MCP-1–induced
firm adhesion to plates coated with ICAM-1, while adhesion to
plates coated with VCAM-1 was intact (Fig. 3B).
Previous studies have reported that chemokine-mediated
activation of b2 integrins was essential for THP-1 cell adhesion
and subsequent transmigration through endothelial monolayers
[7,8,38]. Therefore, the effect of SIRPa overexpression on
transendothelial migration (TEM) of THP-1 cells was examined
by transmigration assay. In mock-transfected THP-1 cells, MCP-1
triggered strong THP-1 cell migration across HMEC-1 monolay-
ers. As shown in Figure 4, more than 20% of total applied THP-1
cells were migrated across TNFa–activated HMEC-1 monolayers
after 3 h incubation. In contrast, MCP-1–triggered transmigration
of THP-1 cells that were overexpressed with SIRPa was strongly
reduced (Fig. 4). In both mock-transfected and SIRPa overex-
pressed THP-1 cells, spontaneous migration of THP-1 cells in the
absence of MCP-1 was minimal (data not shown).
Leukocyte b2 integrin–mediated cell firm adhesion initiates cell
shape changes and spreading of monocytes, events that must occur
for subsequent cellular locomotion and transmigration. Next we
investigated the effect of SIRPa overexpression on TNFa– and
MCP-1–stimulated actin polymerization and cell spreading in
THP-1 cells. SIRPa– or mock– transfected THP-1 cells were
stimulated with TNFa or MCP-1 for 30 minutes, then fixed, and
labeled with rhodamine-conjugated phalloidin to visualize actin
filaments. As a control, mock–transfected THP-1 cells were
pretreated with cytochalasin D to inhibit actin polymerization
[39]. Labeled monocytes were mounted on coverslips and images
were obtained using confocal microscopy. As shown in Figure 5,
confocal microscope images showed that mock– transfected THP-
1 cells exposed to TNFa or MCP-1 underwent morphological
changes resulting in multiple pseudopods (arrowheads) with
abundant actin filaments, and that this process was inhibited by
Figure 2. SIRPa overexpression in THP-1 cells and its effect on
cell surface expression of b2 integrins and CCR2. THP-1 cells were
transfected with the empty pcDNA3.1 vector (Mock) or the SIRPa-
encoding pcDNA3.1 vector (SIRPa). A: SIRPa protein level in SIRPa–o r
mock– transfected THP-1 cells; B: Cell surface SIRPa expression in
Mock– and SIRPa–transfected THP-1 cells; C: THP-1 cell surface
expression of CD11a, CD11b, CD11c and CCR2. Note that SIRPa
overexpression significantly suppressed MCP-1–induced up-regulation
of THP-1 surface expression of CD11b and CD11a but not CCR2, and
that SIRPa overexpression did not affect the basal level of b2 integrins.
All data are mean6SD of three independent experiments.
doi:10.1371/journal.pone.0003291.g002
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stimulated actin polymerization and cell spreading had occurred in
THP-1 cells with SIRPa overexpression (Fig. 5).
The phagocytic function of THP-1 cells is also dependent on b2
integrins [40,41,42]. Next we examined the effect of SIRPa
overexpression on the capacity of THP-1 cells to engulf
fluorescein–labeled E. coli K12 bioparticles. As shown by confocal
images in Figure 6A, the mock-transfected THP-1 cells showed a
Figure 3. SIRPa overexpression in THP-1 cells decreases MCP-
1–stimulated adhesion. A: Micrographs and histograms show THP-1
cells adhered to HMEC-1 monolayers. Bar=20 mm. B: MCP-1–depen-
dent adhesion of SIRPa– or mock–transfected THP1 monocytes to
plates coated with ICAM-1 or VCAM-1. In separate experiments,
monocytes were pretreated with 50 mM Bt2cAMP to determine
background integrin-independent nonspecific adhesion. All data are
mean6SD (n=3) of three independent experiments.
doi:10.1371/journal.pone.0003291.g003
Figure 4. SIRPa overexpression reduces the MCP-1–induced
migration of THP-1 cells across HMEC-1 monolayers pre-
activated with 25 ng/mL TNFa. All data are mean6SD (n=3) of
three independent experiments.
doi:10.1371/journal.pone.0003291.g004
Figure 5. TNFa and MCP-1–induced cell spreading and actin
polymerization in THP-1 cells. SIRPa– or mock–transfected THP-1
cells were stimulated with TNFa or MCP-1 for 30 minutes, fixed, and
labeled with rhodamine-conjugated phalloidin to visualize actin
filaments. As a negative control, mock–transfected THP-1 cells were
pretreated with cytochalasin D (Mock+Cyt. D). Bar=20 mm.
doi:10.1371/journal.pone.0003291.g005
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cles after 3 h incubation (Fig. 6A, arrows), while in SIRPa–
transfected THP-1 cells, uptake of fluorescein–conjugated bacteria
particles was strongly reduced. The quantitative analysis of
uptaking fluorescein–conjugated bacteria particles by THP-1 cells
was shown in Figure 6B. Taken together, these results clearly show
that SIRPa overexpression in THP-1 cells reduces various
inflammatory responses mediated by leukocyte b2 integrins.
Discussion
Recent studies have demonstrated that SIRPa is involved in
regulating various inflammatory responses of leukocytes, in
particular leukocyte chemotaxis and phagocytosis. By studying
the leukocyte b2 integrin-mediated functional changes in THP-1
cells after downregulation or overexpression of SIRPa level, we
show that SIRPa negatively regulates b2 integrin-mediated THP-1
cell inflammatory responses, such as adhesion, transendothelial
migration and phagocytosis.
Correlation between SIRPa protein level and CD11b/
CD18-mediated cellular functions in THP-1 cells
Ligation of SIRPa with its extracellular ligand CD47 results in
phosphorylations of SIRPa ITIMs, which in turn, leads to their
association with SH2-domain-containing protein tyrosine phos-
photases SHP-1 and SHP-2 [16,17] to delivers signals that
regulate a variety of cellular functions [14]. Binding of SIRPa by
antibody or CD47 recombinant inhibits many leukocyte functions,
including phagocytosis [18,19], tumour-necrosis factor production
[20] and in vitro transmigration [21,22]. Activation of SIRPa by
arterial elastic laminae also inhibits monocyte adhesion [23].
Fibroblasts expressing a SIRPa mutant lacking ITIMs-containing
cytoplasmic tail showed increased formation of focal adhesions
and actin stress fibres in response to interaction with extracellular
matrix, suggesting that SIRPa is also involved in mediating
outside-in signal transduction during cell-matrix interaction. Using
THP-1 cell as model cell line, here we show that SIRPa protein
level is downregulated by AGEs treatment, which is also correlated
to an enhanced cell surface expression of b2 integrins and b2
integrins-mediated cell adhesion (Fig. 1). The finding of SIRPa
reduction in AGEs-treated THP-1 cells is supported by a recent
report that mouse macrophages have lower SIRPa expression
level following LPS stimulation [43]. The correlation between
SIRPa expression level and chemoattractant-induced cell surface
upregulation of b2 integrins and b2 integrins-mediated THP-1 cell
inflammatory responses is further characterized in THP-1 cells
overexpressed with SIRPa (Fig. 2–6). The results not only confirm
the inhibitory function of SIRPa on THP-1 inflammatory responses,
but also indicated that the role of SIRPa in THP-1 cells is through
affecting the functions of b2 integrins, particularly CD11b/CD18. It
is worthy to note that overexpression of SIRPa does not alter the
basal level of b2 integrin expression but the upregulation of b2
integrins by MCP-1 stimulation, suggesting that SIRPa is one of
essential molecules along the signal pathways that may regulate the
synthesis, transportation and translocation process of b2 integrins.
Moreover, if AGEs and other inflammatory factors can affect b2
integrin expression and function through down-regulating SIRPa,i t
might be reasonable to conclude that SIRPa can mediate an inside-
out signal in regulating b2 integrin function.
SIRPa as a negative regulator in monocyte recruitment
during inflammation
The expression of b2 integrins and adhesion molecules in
monocytes is regulated by chemokines such as MCP-1, SDF-1
alpha and RANTES [32,44,45,46]. The positive correlation
between CD11b expression in circulating monocytes and the
degree of monocyte infiltration into the proatherogenic vascular
wall has been well-documented [8,47,48]. The increased expres-
sion of monocyte CD11b under pro-inflammatory conditions
enhanced MCP-1–mediated chemotaxis in vitro [8], induced excess
monocyte adhesion to vascular endothelium, and increased
formation of neointima and atherosclerotic plaques [48]. Although
SIRPa overexpression did not affect surface expression of CCR2,
the receptor for MCP-1, it resulted in a profound reduction of
MCP-1–mediated upregulation of THP-1 cell cell surface b2
integrins and THP-1 cell TEM. In addition to reduction of CD11b
and other b2 integrins, our study has also demonstrated that
overexpressing SIRPa in THP-1 cells display less cell spreading
and actin polymerization in response to chemokine stimulation.
The mechanism by which SIRPa modulates chemokine-induced
cell spreading and actin polymerization is unknown although
several possibilities exist: a) directly activates protein phosphatase
and initiates signal pathways that attenuate filament actin
polymerization and cell spreading, and b) binding to integrin-
associated protein CD47 and modulating the integrin functions.
Since SIRPa is a cellular ligand of CD47, which can augment the
functions of integrins of the b1, b2 and b3 families via initiating
heterotrimeric Gi protein signaling [49], thus modulating a range
of cell activities including cell motility and adhesion, and leukocyte
Figure 6. SIRPa overexpression in THP-1 cells impairs cell
phagocytic function. Fluorescently labeled bacteria were incubated
with SIRPa– or mock–transfected THP-1 cells for 3 h. A: Images of
phagocytosis of bacteria by THP-1 cells; B: Quantitative analysis of
bacteria phagocytosis by THP-1 cells. Bar=20 mm. All data are
mean6SD (n=4) of four independent experiments.
doi:10.1371/journal.pone.0003291.g006
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bacteria by THP-1 cells, an event that is largely dependent on b2
integrin and actin polymerization, was significantly reduced by
overexpression of SIRPa. This result was in agreement with the
previous finding that SIRPa contributes to down-regulating the
macrophage phagocytic response [18]. In summary, the present
study demonstrates for the first time that SIRPa overexpression
potently inhibits the various inflammatory responses of THP-1
monocytes/macrophages mediated by b2 integrins. The induction
of SIRPa expression in THP-1 cells led to a reduction of
chemokine-induced cell surface expression of b2 integrins, which
eventually resulted in less cell adhesion, cellular spreading, cell
transmigration and phagocytosis. This observation suggests that
SIRPa may function to decrease transendothelial migration of
monocytes or other circulating leukocytes, reduce the burden of
inflammatory cells in atheroma, and ultimately decrease plaque
mass under atherogenic conditions. Since migration of monocytes
across blood vessel lining endothelial monolayers is a key
component during early stage of atherosclerosis, such an outcome
would indicate that SIRPa overexpression in monocytes or
macrophages has an anti-atherogenic effect and that SIRPa is a
potential target in therapeutical implications.
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